412 related articles for article (PubMed ID: 8843416)
1. Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor.
Sotiropoulos A; Moutoussamy S; Renaudie F; Clauss M; Kayser C; Gouilleux F; Kelly PA; Finidori J
Mol Endocrinol; 1996 Aug; 10(8):998-1009. PubMed ID: 8843416
[TBL] [Abstract][Full Text] [Related]
2. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B.
Smit LS; Vanderkuur JA; Stimage A; Han Y; Luo G; Yu-Lee LY; Schwartz J; Carter-Su C
Endocrinology; 1997 Aug; 138(8):3426-34. PubMed ID: 9231797
[TBL] [Abstract][Full Text] [Related]
5. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton.
Rico-Bautista E; Negrín-Martínez C; Novoa-Mogollón J; Fernández-Perez L; Flores-Morales A
Exp Cell Res; 2004 Mar; 294(1):269-80. PubMed ID: 14980520
[TBL] [Abstract][Full Text] [Related]
7. Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B.
Stofega MR; Herrington J; Billestrup N; Carter-Su C
Mol Endocrinol; 2000 Sep; 14(9):1338-50. PubMed ID: 10976913
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins.
Hansen JA; Lindberg K; Hilton DJ; Nielsen JH; Billestrup N
Mol Endocrinol; 1999 Nov; 13(11):1832-43. PubMed ID: 10551777
[TBL] [Abstract][Full Text] [Related]
9. Identification of growth hormone receptor (GHR) tyrosine residues required for GHR phosphorylation and JAK2 and STAT5 activation.
Wang X; Darus CJ; Xu BC; Kopchick JJ
Mol Endocrinol; 1996 Oct; 10(10):1249-60. PubMed ID: 9121492
[TBL] [Abstract][Full Text] [Related]
10. Distinct cytoplasmic regions of the growth hormone receptor are required for activation of JAK2, mitogen-activated protein kinase, and transcription.
Sotiropoulos A; Perrot-Applanat M; Dinerstein H; Pallier A; Postel-Vinay MC; Finidori J; Kelly PA
Endocrinology; 1994 Oct; 135(4):1292-8. PubMed ID: 7925092
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone (GH)-stimulated insulin-like growth factor I gene expression is mediated by a tyrosine phosphorylation pathway depending on C-terminal region of human GH receptor in human GH receptor-expressing Ba/F3 cells.
Yoshizato H; Tanaka M; Nakai N; Nakao N; Nakashima K
Endocrinology; 2004 Jan; 145(1):214-20. PubMed ID: 14551225
[TBL] [Abstract][Full Text] [Related]
13. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
[TBL] [Abstract][Full Text] [Related]
14. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms.
Ram PA; Waxman DJ
J Biol Chem; 1999 Dec; 274(50):35553-61. PubMed ID: 10585430
[TBL] [Abstract][Full Text] [Related]
15. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone (GH) induces the formation of protein complexes involving Stat5, Erk2, Shc and serine phosphorylated proteins.
Dinerstein-Cali H; Ferrag F; Kayser C; Kelly PA; Postel-Vinay M
Mol Cell Endocrinol; 2000 Aug; 166(2):89-99. PubMed ID: 10996427
[TBL] [Abstract][Full Text] [Related]
17. Activation of the signal transducers and activators of transcription signaling pathway by growth hormone (GH) in skin fibroblasts from normal and GH binding protein-positive Laron Syndrome children.
Freeth JS; Silva CM; Whatmore AJ; Clayton PE
Endocrinology; 1998 Jan; 139(1):20-8. PubMed ID: 9421393
[TBL] [Abstract][Full Text] [Related]
18. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription.
Ferrag F; Chiarenza A; Goffin V; Kelly PA
Mol Endocrinol; 1996 Apr; 10(4):451-60. PubMed ID: 8721989
[TBL] [Abstract][Full Text] [Related]
19. A role for Grb2-associated binder-1 in growth hormone signaling.
Kim SO; Loesch K; Wang X; Jiang J; Mei L; Cunnick JM; Wu J; Frank SJ
Endocrinology; 2002 Dec; 143(12):4856-67. PubMed ID: 12446613
[TBL] [Abstract][Full Text] [Related]
20. Prolactin signal transduction to milk protein genes: carboxy-terminal part of the prolactin receptor and its tyrosine phosphorylation are not obligatory for JAK2 and STAT5 activation.
Goupille O; Daniel N; Bignon C; Jolivet G; Djiane J
Mol Cell Endocrinol; 1997 Mar; 127(2):155-69. PubMed ID: 9099911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
